SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-22-027121
Filing Date
2022-09-29
Accepted
2022-09-29 08:30:26
Documents
25
Period of Report
2022-09-28
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 42457
2 ex99-1.htm EX-99.1 12429
3 ex99-1_001.jpg GRAPHIC 390764
4 ex99-1_002.jpg GRAPHIC 151891
5 ex99-1_003.jpg GRAPHIC 211063
6 ex99-1_004.jpg GRAPHIC 340428
7 ex99-1_005.jpg GRAPHIC 187974
8 ex99-1_006.jpg GRAPHIC 153847
9 ex99-1_007.jpg GRAPHIC 166868
10 ex99-1_008.jpg GRAPHIC 166968
11 ex99-1_009.jpg GRAPHIC 140608
12 ex99-1_010.jpg GRAPHIC 126240
13 ex99-1_011.jpg GRAPHIC 338467
14 ex99-1_012.jpg GRAPHIC 287992
  Complete submission text file 0001493152-22-027121.txt   3897044

Data Files

Seq Description Document Type Size
15 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT anix-20220928.xsd EX-101.SCH 3218
16 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT anix-20220928_lab.xml EX-101.LAB 34240
17 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT anix-20220928_pre.xml EX-101.PRE 22353
19 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3621
Mailing Address 3150 ALMADEN EXPRESSWAY, SUITE 250 SAN JOSE CA 95118
Business Address 3150 ALMADEN EXPRESSWAY, SUITE 250 SAN JOSE CA 95118 408-708-9808
Anixa Biosciences Inc (Filer) CIK: 0000715446 (see all company filings)

IRS No.: 112622630 | State of Incorp.: DE | Fiscal Year End: 1031
Type: 8-K | Act: 34 | File No.: 001-37492 | Film No.: 221277780
SIC: 2834 Pharmaceutical Preparations